An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Understanding Alzheimer’s and the Role of Clinical Trials Clinical trials for Alzheimer’s are transforming the landscape of treatment and support for those living with this challenging condition. With ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

In the study, "Deferiprone in Alzheimer Disease: A Randomized Clinical Trial," published in JAMA Neurology, researchers ...

Alzheimer's disease researchers found that when they aimed a TMS device at the right spot in the brain, it could slow the ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

In the effort to expand approaches to treating Alzheimer’s beyond targeting amyloid, some companies have sought to target ...

Two blood tests currently in development have shown 'very high accuracy' in detecting tell-tale signs of Alzheimer's disease, ...

Frailty is a strong predictor of dementia risk, with risk increasing by 40% with each 4-5 additional age-related health conditions.

Frailty accelerated four to nine years before dementia started, and it was positively linked with the risk for dementia, according to four studies conducted in the United States and the United Kingdom ...